Abstract:Central nervous system (CNS) monoamine deficits have been linked to a number of pathological conditions such as major depressive disorder. Individual biological variations in 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) might account for the variation in responses of neurotransmitter systems observed after the administration of clomipramine. The prolactin response to clomipramine has been widely used to assess CNS functioning. This open label study investigates the prolactin response induced by clomipramine in the plasma of healthy volunteers and whether it is related to changes in monoamine metabolites. The effects of clomipramine challenge on prolactin, 5-HIAA, HVA and MHPG were measured in 12 healthy volunteers. Samples were drawn directly before and 50 min after clomipramine infusion. A statistically significant increase in serum prolactin concentrations was measured in women 50 min after CMI infusion, but not in men. We found no significant increases in the serum monoamine metabolite concentrations 50 min after CMI infusion. Changes in HVA and 5-HIAA correlated statistically significantly and positively with the amount of prolactin release in the whole sample. Furthermore, positive correlations were found between ∆(50-0 min) 5-HIAA and ∆(50-0 min) HVA, although we did not find a correlation between ∆(50-0 min) prolactin and ∆(50-0 min) MHPG after clomipramine challenge. The pronounced prolactin release in healthy adult women might indicate a higher physiological sensitivity. Correlations between intra-individual changes in HVA, 5-HIAA and serum prolactin might indicate a central nervous effect of clomipramine on monoamine turnover. We conclude that monoamine changes in relation to prolactin response after clomipramine challenge may be suitable for characterizing the relationship between central serotonergic and dopaminergic function.

Effect of M-Chlorophenylpiperazine on Plasma Homovanillic Acid Concentrations in Healthy Subjects

Effects of Meta-Chlorophenylpiperazine on Neuroendocrine and Behavioral Responses in Male Schizophrenic Patients and Normal Volunteers

Serotonin Function in Schizophrenia: Effects of Meta- Chlorophenylpiperazine in Schizophrenia Patients and Healthy Subjects

Psychomotor Slowing, Neuroendocrine Responses, and Behavioral Changes after Oral Administration of Meta-Chlorophenylpiperazine in Normal Volunteers

Clozapine Treatment and Its Effect on Neuroendocrine Responses Induced by the Serotonin Agonist, M-Chlorophenylpiperazine

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects

Pindolol Pretreatment Blocks Stimulation by Meta-Chlorophenylpiperazine of Prolactin but Not Cortisol Secretion in Normal Men

Hostility is Associated with a Low Prolactin Response to Meta-Chlorophenylpiperazine in Abstinent Alcoholics.

Haloperidol and Clozapine Treatment and Their Effect on M-Chlorophenylpiperazine-Mediated Responses in Schizophrenia - Implications for the Mechanism of Action of Clozapine

Lower Baseline Plasma Cortisol and Prolactin Together with Increased Body Temperature and Higher Mcpp-Induced Cortisol Responses in Men with Pedophilia

Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia. Serotonin-dopamine Interactions As a Target for Treatment.

Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts.

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.

Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study

Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a <SUP>1</SUP>H MRS study

Effect of Pindolol Pretreatment on Mk-212-Induced Plasma-Cortisol and Prolactin Responses in Normal Men

Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses

Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY

The Cimetidine-Induced Increase in Prolactin Secretion in Schizophrenia - Effect of Clozapine

Central Catecholamine Metabolism in Vivo and the Cognitive and Motor Deficits in Parkinson's Disease.